Health Catalyst Research Development Over Time
| HCAT Stock | USD 2.15 0.01 0.46% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Health Catalyst Performance and Health Catalyst Correlation. Is there potential for Health Care Technology market expansion? Will Health introduce new products? Factors like these will boost the valuation of Health Catalyst. Market participants price Health higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Health Catalyst listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Health Catalyst is measured differently than its book value, which is the value of Health that is recorded on the company's balance sheet. Investors also form their own opinion of Health Catalyst's value that differs from its market value or its book value, called intrinsic value, which is Health Catalyst's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Health Catalyst's market value can be influenced by many factors that don't directly affect Health Catalyst's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Health Catalyst's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Catalyst is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Health Catalyst's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Research Development Analysis
Compare Health Catalyst and related stocks such as Nano X Imaging, Prelude Therapeutics, and Orchestra BioMed Holdings Research Development Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NNOX | 672 K | 672 K | 672 K | 672 K | 672 K | 672 K | 672 K | 672 K | 672 K | 2.7 M | 9.2 M | 17.1 M | 26.5 M | 26 M | 20.2 M | 23.2 M | 16.1 M |
| PRLD | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 24.3 M | 48.2 M | 86.8 M | 92.9 M | 103.4 M | 118 M | 135.7 M | 76.4 M |
| OBIO | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 12.9 M | 21.9 M | 33.8 M | 42.8 M | 49.2 M | 27.5 M |
| CRBU | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 34.4 M | 52.3 M | 82.2 M | 112.1 M | 130.2 M | 149.7 M | 79.7 M |
| ENTA | 9.7 M | 15.1 M | 16.8 M | 18.7 M | 23.2 M | 40.5 M | 57.5 M | 94.9 M | 142.2 M | 136.8 M | 174.1 M | 164.5 M | 163.5 M | 131.5 M | 106.7 M | 122.8 M | 89.9 M |
| OM | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 23.3 M | 28.9 M | 36.7 M | 48.9 M | 57.3 M | 38.4 M | 44.2 M | 40.3 M |
| PYXS | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 8.6 M | 51.1 M | 86.1 M | 49.6 M | 58.7 M | 67.6 M | 46.8 M |
| TNYA | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 31.1 M | 54.4 M | 94.5 M | 98 M | 86.7 M | 99.8 M | 71.1 M |
| HSDT | 4.2 M | 4.2 M | 4.2 M | 171.8 K | 4.5 M | 3.6 M | 3.6 M | 14.4 M | 9.9 M | 8.1 M | 4.6 M | 6 M | 4.3 M | 2.9 M | 3.7 M | 4.2 M | 5.9 M |
Health Catalyst and related stocks such as Nano X Imaging, Prelude Therapeutics, and Orchestra BioMed Holdings Research Development description
My Equities
My Current Equities and Potential Positions
| Health Catalyst | HCAT |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 10897 South River |
| Exchange | NASDAQ Exchange |
USD 2.15
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.